A Pilot Randomized Controlled Trial of Brief Cognitive-Behavioral Therapy for Anxiety in Patients with Terminal Cancer
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Learning Objectives: After completing this course, the reader will be able to: Explain the current state of evidence-based treatment for anxiety in patients with cancer and the need for tailored intervention, especially for those with terminal cancer.Discuss and utilize methods for increasing access to psychosocial intervention for patients with cancer who suffer significant physical and psychological morbidity.Describe the effect of a brief cognitive-behavioral therapy intervention tailored to the needs of patients with terminal cancer and comorbid anxiety symptoms. CME This article is available for continuing medical education credit at CME.TheOncologist.com Introduction.: Patients with terminal cancer often experience marked anxiety that is associated with poor quality of life. Although cognitive-behavioral therapy (CBT) is an evidence-based treatment for anxiety disorders, the approach needs to be adapted to address realistic concerns related to having cancer, such as worries about disease progression, disability, and death. In this pilot randomized controlled trial (clinicaltrials.gov identifier NCT00706290), we examined the feasibility and potential efficacy of brief CBT to reduce anxiety in patients with terminal cancer. Methods.: We adapted CBT by developing treatment modules targeting skills for relaxation, coping with cancer worries, and activity pacing. Adults with incurable malignancies and elevated anxiety based on the Hamilton Anxiety Rating Scale (HAM-A) were randomly assigned to individual CBT or a waitlist control group. Primary outcomes included the number of completed CBT visits and the change in HAM-A scores from baseline to 8-week follow-up per a treatment-blind evaluator. The feasibility criterion was 75% adherence to the intervention. Results.: We randomized 40 patients with terminal cancers to CBT (n = 20) or waitlist control (n = 20) groups; 70% completed posttreatment assessments. Most patients who received CBT (80%) participated in at least five of the required six therapy sessions. Analysis of covariance models, adjusted for baseline scores, showed that those assigned to CBT had greater improvements in HAM-A scores compared to the control group, with an adjusted mean difference of –5.41 (95% confidence interval: –10.78 to –0.04) and a large effect size for the intervention (Cohen's d = 0.80). Conclusion.: Providing brief CBT tailored to the concerns of patients with terminal cancer was not only feasible but also led to significant improvements in anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychosocial interventions have been found to be efficacious in reducing anxiety in adults with cancer, as well as having positive long-term effects on quality of life (Osborn et al., 2006; Greer et al, 2012; Jacobsen & Jim, 2008).”
From Utilizing a Manualized Therapy to Provide Parallel Treatment to Older Adults With Cancer and Their Caregivers: A Case Study (2022) · cites this paper as Greer et al, 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence suggests that CBT may benefit advanced-stage cancer patients by reducing anxiety symptoms, improving QL [33], and decreasing psychiatric disorders, which have been observed in cancer patients who were classified as high-risk for the development of such disorders [25].”
From A phase II study in advanced cancer patients to evaluate the early transition to palliative care (the PREPArE trial): protocol study for a randomized controlled trial. (2015) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 7×
“Although clinician ratings on the HAM-A and MADRS correlated significantly at baseline (r .67, p .001), the average decrease in MADRS scores of 6.07 points (SD 12.89) for the CBT group did not differ significantly from the 0.69-point (SD 6.55) reduction for the control group (between-group mean difference –5.38, SE 3.…”
BackgroundInfluentialThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 1×
“The primary outcome measure for the study was the total score on the HAM-A [23].”
BackgroundImpact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813 · cited 5×
“The IES is a validated, 15-item self-report questionnaire that assesses intrusive and avoidant thoughts related to a stressor, in this case cancer.”
MethodInfluentialThe functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 1×
“Finally, to assess quality of life, we used the Functional Assessment of Cancer Therapy-General (FACT-G) Questionnaire [30], which has been administered in multiple medical settings to patients with diverse tumor types.”
MethodLenggenhager, J. (1947) · PubMed · Cited by 1,772
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“Although CBT is a well-established and efficacious treatment for anxiety disorders in the general population [19], the intervention usually targets unrealistic fears and maladaptive avoidance behaviors.”
BackgroundCancer Care for the Whole Patient: Meeting Psychosocial Health Needs
(2008) · National Academies Press eBooks · doi:10.17226/11993 · Cited by 708
Psychiatric morbidity and its recognition by doctors in patients with cancer
Fallowfield, L., Ratcliffe, D., Jenkins, V, & Saul, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1724 · Cited by 694 · cited 1×
“Patients with poor-prognosis cancers are at heightened risk for psychiatric morbidity and suffer considerable disease burden that may limit their ability to engage in psychosocial services [31].”
BackgroundAnxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic
NOYES, R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.8.1083 · Cited by 684
Cited by
Items 101–111 of 111
Satheeshkumar, P. S., Пили, Р., Thazhe, S. B. K., Sukumar, R., Mohan, M. P., Boakye, E. A., & Epstein, J. B. (2024) · PLOS mental health. · doi:10.1371/journal.pmen.0000005 · Cited by 1
Li, W., Feng, Y., Zhao, M., Chen, R., Xu, Y., Lv, H., Xing, P., Chen, S., Meng, H., & Wang, Y. (2025) · Psycho-Oncologie · doi:10.18282/po4620
Kuraś-Szczepańska, I., Biernacka, B., Gieroba, T., Mazur, A., Wójcik, B., & Rosłonek, D. (2025) · Journal of Modern Science · doi:10.13166/jms/214330
Fujisawa, D., Yoshikawa, E., Fujimori, M., 幸子, 荒., Kobayakawa, M., Kurata, A., Kayano, A., Ichikura, K., Igarashi, Y., Otani, H., et al. (2025) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaf209 · Cited by 1
Jalali, A., Ghasemianrad, M., Khazaie, H., Jalali, R., Chavoshani, F., Khalili, M., & Kazeminia, M. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02235-1 · Cited by 2
Borgogna, N. C., Owen, T., Spencer, S. D., Jo, D., Jafari, M., Vaughn, J., Nia, N. N., Shegedin, M., Meyer, C. L., Johnson, D. A., et al. (2026) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2026.2633192 · Cited by 1
Romano, B. W., Watanabe, D. M., Chaves, G., Perez, G. H., & Lopes, S. M. P. (2016) · Revista da SBPH · doi:10.57167/rev-sbph.19.411 · Cited by 1
Yusufov, M., Pollak, K. I., Poort, H., Beaussant, Y., Tarbi, E. C., Leiter, R. E., & Tulsky, J. A. (2026) · Palliative & Supportive Care · doi:10.1017/s1478951526102739
“To manage these challenges, clinicians frequently prescribe controlled substances, including opioids (Greer et al. 2012) and sedative hypnotics (benzodiazepines/sleep aids).”
Research Progress on Comorbid Depression in Cancer Patients
姚, 瑶. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662345
Fang, L., Tan, Y., & Li, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1881099
“Concurrently, psychological interventions encompassing cognitive-behavioral therapy, relaxation training, and mindfulness-based approaches have shown promise in addressing the emotional and cognitive dimensions of dyspnea (20, 21).”
Palliative care in oncology: Symptom management and supportive therapies
Sarma, G., Nath, J., & Medhi, P. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-38307-6.00007-7
Metadata
- Authors
- Greer, J. A., Traeger, L., Bemis, H., Solis, J., Hendriksen, E. S., Park, E. R., Pirl, W. F., Temel, J. S., Prigerson, H. G., & Safren, S. A.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Greer, Joseph A.
- ORCID
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-11
- Volume
- 17
- Issue
- 10
- Pages
- 1337-1345
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- PMC
- PMC3481900
- OpenAlex
- W2171324372
- Cited by
- 111
- References
- 39
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 15 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 4 · 2015: 3 · 2014: 5
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R03CA128478)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- terminal cancer, anxiety, cognitive behavioral therapy, brief psychotherapy, cancer-related anxiety, treatment feasibility, relaxation training, activity pacing, psychosocial interventions, quality of life, medication adherence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anxiety Disorders, Female, Humans, Male, Middle Aged, Neoplasms, Pilot Projects, Primary Health Care, Cognitive Behavioral Therapy, Treatment Outcome, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.